arrow
D

David B. Meya

University of Minnesota
H指数:48
被引数:9,746

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictive Value of C-reactive Protein for Hospitalization and Mortality Among People With Advanced HIV Disease in Uganda Receiving the WHO-recommended Package of Care

乌干达接受世界卫生组织推荐护理套餐的晚期HIV疾病患者中,C反应蛋白对住院和死亡率的预测价值

2025-11-010
PRE
Prevalence and Factors Associated With Aspergillus galactomannan Antigenemia Among People With Advanced HIV Disease in Uganda, 2023

乌干达晚期HIV疾病患者中曲霉菌半乳甘露聚糖抗原血症的患病率及其相关因素,2023年

2025-10-080
OAAI
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial

评估低剂量氟胞嘧啶在隐球菌性脑膜炎治疗中的应用:一项临床试验

2025-09-010
PRE
Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis

脑脊液单核细胞表型及活化预测因子:HIV相关隐球菌性脑膜炎患者2周及1年生存率研究

2025-09-010
PRE
A clinical practice guideline for tuberculous meningitis

结核性脑膜炎临床实践指南

2025-08-180
PRE
Cerebral Perfusion Pressures and Implications on Clinical Outcomes and Medical Management in Cryptococcal Meningitis

脑灌注压及对隐球菌性脑膜炎临床结局与医疗管理的影响

2025-08-010
OAAI
Single nucleotide polymorphisms are associated with strain-specific virulence differences among clinical isolates of Cryptococcus neoformans (vol 15, 10491, 2024)

单核苷酸多态性与临床分离株中新型隐球菌菌株特异性的毒力差异相关(vol 15, 10491, 2024)

2025-03-130
OA
Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitis

脑脊液白细胞浸润和激活的神经免疫介质对HIV相关性隐球菌性脑膜炎生存的影响

2025-02-100
OAAI
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in Human Immunodeficiency Virus-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa
2025-01-010
PRE